跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,034 条关于
“Vyome Holdings”
全部
1,034
临床试验
91
药物
60
机构
151
资讯
732
10个月前
Vyome Holdings Reports Positive Phase 2 Results for VT-1953 in Malignant Fungating Wounds
去年
Vyome Therapeutics Secures Nasdaq Approval for Merger with ReShape Lifesciences, Targeting $100B Inflammatory Disease Market
去年
Vyome Therapeutics' VT-1953 Shows Promise in Phase 2 Trial for Malignant Fungating Wounds
7个月前
Vyome Seeks Orphan Drug Status for VT-1953 as Independent Analysis Values Asset at $1 Billion Post-Phase 3
9个月前
Vyome's VT-1953 Achieves Primary Endpoints in Phase 2 Trial for Malignant Fungating Wounds
去年
Vyome's VT-1953 Demonstrates Significant Efficacy in Phase 2 Trial for Malignant Fungating Wounds
去年
ReShape Lifesciences Announces Merger with Vyome and Asset Sale to Biorad Amid Q1 2025 Financial Results
去年
Vyome Therapeutics Goes Public Through Reverse Merger, Advances Phase II Trial for Rare Cancer Wound Condition
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
第 1 页,共 74 页
上一页
下一页